How chemotherapy becomes more effective

Researchers from the University of Zurich have found a cellular brake that protects cancer cells from chemotherapy -- and they demonstrate which medication can be used to render it inoperative. Their study published in the journal Natural Structural and Molecular Biology provides the molecular basis for promising therapeutic advances.

Although many have already been in use for decades, their mode of action is still unknown. The new research results now challenge a mechanism of action that was previously proposed for a group of drugs and supported with experiments: the I-inhibitor Camptothecin (Top1 inhibitor for short) and its derivatives used in chemotherapy, and .

Problem: emergency cellular brake restricts effectiveness

For a long time, the toxicity of the top1-inhibitors was attributed to discontinuities in the cancer cells' DNA that inevitably caused breaks in the chromosomes during the duplication of the DNA. The team headed by Professor Massimo Lopes at the University of Zurich's Institute of Molecular has now identified a mechanism with which protect themselves against damage caused by Top1 inhibitions: Using , the researchers were able to demonstrate that Top1 inhibitors can cause the replication forks that develop during the duplication of the DNA to be restructured. "Reversed" replication forks, or "chicken-foot" structures as they are also known, are formed. This remodeling of the replication forks provides the cancer cells with the time they need to repair the lesion in the DNA and thus prevent disparately cytotoxic chromosomal breakage.

"Until now, the assumed mechanism of action of Top1 inhibitors was comparable to a train hurtling towards an obstacle without brakes that inevitably ends up derailing," explains Massimo Lopes, commenting on the results. "What we have now discovered is the emergency brake, which the cells activate themselves to protect themselves from the inhibitor." Arnab Ray-Chaudhuri, who made a considerable contribution to the study, draws the following conclusion: "Thanks to the discovery of this mechanism, we now understand why chemotherapy does not always work as expected with these drugs."

The existence of such DNA structures was hypothesized many years ago, but it has only just been confirmed in human cells by Lopes's group. These chicken-foot structures are even surprisingly common with clinically relevant doses of Top1 inhibitors.

Solution: render emergency brake inoperative

The new observations reveal an interesting coincidence: In pulling the emergency brake, a family of enzymes that recently attracted a great deal of interest as a potential target for new cancer therapies is involved in the restructuring: the poly-ADP-ribose polymerases, or PARPS for short. After all, PARP inhibitors increase the sensitivity of cancer cells to different drugs that harm the DNA, including Top1 inhibitors. The new study reveals why: PARP inhibition hinders the reversal of the replication forks and increases the number of chromosomal breaks caused by Top1 inhibitors. Massimo Lopes and his team thus provide a clear for the clinical observations described and pave the way for promising therapeutic advances.

Massimo Lopes's team is currently investigating whether the same or a similar mechanism is activated by other classes of chemotherapeutics and which cellular factors are involved in this molecular "emergency brake". The aim is to identify tumors in which this mechanism is not active or inhibit the mechanism pharmacologically to improve the efficacy of chemotherapy.

More information: A. Ray Chaudhuri, Y. Hashimoto, R. Herrador, K.J. Neelsen, D. Fachinetti, R. Bermejo, A. Cocito, V. Costanzo and M. Lopes. Toposiomerase I poisoning results in PARP-mediated replication fork reversal. Nature Structural and Molecular Biology. 4 March, 2012. Doi: 10.1038/nsmb.2258

Related Stories

Stomach bacterium damages human DNA

date Sep 06, 2011

The stomach bacterium Helicobacter pylori is one of the biggest risk factors for the development of gastric cancer, the third most common cause of cancer-related deaths in the world. Molecular biologists from the University of Zur ...

Scientists identify molecular basis for DNA breakage

date Jul 19, 2011

Scientists from the Hebrew University have identified the molecular basis for DNA breakage, a hallmark of cancer cells. The findings of this research have just been published in the journal Molecular Cell.

Recommended for you

DNA blood test detects lung cancer mutations

date 19 hours ago

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers ...

Tumors prefer the easy way out

date 21 hours ago

Tumor cells become lethal when they spread. Blocking this process can be a powerful way to stop cancer. Historically, scientists thought that tumor cells migrated by brute force, actively pushing through whatever ...

Brain tumors may be new targets of Ebola-like virus

date 22 hours ago

Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely new ally against brain cancers—portions of a deadly virus similar to Ebola.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.